{"id":"https://openalex.org/W7225262109","doi":"https://doi.org/10.1093/ofid/ofag630","title":"Early Remdesivir for Patients Who Are Immunocompromised and Hospitalized With COVID-19","display_name":"Early Remdesivir for Patients Who Are Immunocompromised and Hospitalized With COVID-19","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7225262109","doi":"https://doi.org/10.1093/ofid/ofag630","pmid":"https://pubmed.ncbi.nlm.nih.gov/42985210","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13732734"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofag630","doi":"https://doi.org/10.1093/ofid/ofag630","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag630","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofag630","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113121860","display_name":"Kathleen E. Hurwitz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kathleen E Hurwitz","raw_affiliation_strings":["Epidemiology, Headwater Science , Durham, North Carolina ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology, Headwater Science , Durham, North Carolina ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103247711","display_name":"Mark Berry","orcid":"https://orcid.org/0000-0002-8534-2012","observed_orcids":["https://orcid.org/0000-0002-8534-2012"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Berry","raw_affiliation_strings":["Gilead Sciences Virology, , Foster City, California ,"],"raw_orcid":"https://orcid.org/0000-0002-8534-2012","affiliations":[{"raw_affiliation_string":"Gilead Sciences Virology, , Foster City, California ,","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122826776","display_name":"Eunyoung Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"EunYoung Lee","raw_affiliation_strings":["Gilead Sciences Virology, , Foster City, California ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences Virology, , Foster City, California ,","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025379161","display_name":"Kayla Hendrickson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kayla Hendrickson","raw_affiliation_strings":["Epidemiology, Headwater Science , Durham, North Carolina ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology, Headwater Science , Durham, North Carolina ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083104471","display_name":"Nuvan S. Rathnayaka","orcid":"https://orcid.org/0000-0002-9839-9261","observed_orcids":["https://orcid.org/0000-0002-9839-9261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nuvan Rathnayaka","raw_affiliation_strings":["Epidemiology, Headwater Science , Durham, North Carolina ,"],"raw_orcid":"https://orcid.org/0000-0002-9839-9261","affiliations":[{"raw_affiliation_string":"Epidemiology, Headwater Science , Durham, North Carolina ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030992141","display_name":"Valentina A. Shvachko","orcid":"https://orcid.org/0009-0004-3697-7080","observed_orcids":["https://orcid.org/0009-0004-3697-7080"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valentina Shvachko","raw_affiliation_strings":["Gilead Sciences Virology, , Foster City, California ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences Virology, , Foster City, California ,","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032075288","display_name":"Mazin Abdelghany","orcid":"https://orcid.org/0000-0001-5192-8659","observed_orcids":["https://orcid.org/0000-0001-5192-8659"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mazin Abdelghany","raw_affiliation_strings":["Gilead Sciences Virology, , Foster City, California ,"],"raw_orcid":"https://orcid.org/0000-0001-5192-8659","affiliations":[{"raw_affiliation_string":"Gilead Sciences Virology, , Foster City, California ,","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043912107","display_name":"Carrie M. Nielson","orcid":"https://orcid.org/0000-0002-2619-7839","observed_orcids":["https://orcid.org/0000-0002-2619-7839"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carrie M Nielson","raw_affiliation_strings":["Gilead Sciences Virology, , Foster City, California ,"],"raw_orcid":"https://orcid.org/0000-0002-2619-7839","affiliations":[{"raw_affiliation_string":"Gilead Sciences Virology, , Foster City, California ,","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076716488","display_name":"M. Alan Brookhart","orcid":"https://orcid.org/0000-0003-1572-0564","observed_orcids":["https://orcid.org/0000-0003-1572-0564"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Alan Brookhart","raw_affiliation_strings":["Department of Population Health Sciences, Duke University , Durham, North Carolina ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Population Health Sciences, Duke University , Durham, North Carolina ,","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030408366","display_name":"Anand P. Chokkalingam","orcid":"https://orcid.org/0000-0001-5200-3033","observed_orcids":["https://orcid.org/0000-0001-5200-3033"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anand Chokkalingam","raw_affiliation_strings":["Gilead Sciences Virology, , Foster City, California ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences Virology, , Foster City, California ,","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000958441","display_name":"Joshua Aiden Hill","orcid":"https://orcid.org/0000-0002-7665-7100","observed_orcids":["https://orcid.org/0000-0002-7665-7100","https://orcid.org/0000-0002-3617-6142"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joshua A Hill","raw_affiliation_strings":["Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington , Seattle, Washington ,","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center , Seattle, Washington ,"],"raw_orcid":"https://orcid.org/0000-0002-7665-7100","affiliations":[{"raw_affiliation_string":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington , Seattle, Washington ,","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center , Seattle, Washington ,","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5000958441","https://openalex.org/A5113121860"],"corresponding_institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8569977,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"11","first_page":"ofag630","last_page":"ofag630"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/remdesivir","display_name":"remdesivir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9869999885559082},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.9869999885559082},{"id":"https://openalex.org/keywords/in-hospital-mortality","display_name":"in-hospital mortality","score":0.9769999980926514},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.9290000200271606},{"id":"https://openalex.org/keywords/sars-cov-2-variants","display_name":"SARS-CoV-2 variants","score":0.8889999985694885},{"id":"https://openalex.org/keywords/target-trial-emulation","display_name":"target trial emulation","score":0.7110000252723694},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9749000072479248},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.6324999928474426},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6180999875068665},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.4578000009059906},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.41339999437332153},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4065000116825104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3903000056743622},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.3815000057220459},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.37950000166893005},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.35659998655319214},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3465000092983246},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.3452000021934509},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.34209999442100525},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.31679999828338623},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.2996000051498413},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.296099990606308},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.29499998688697815},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.29420000314712524},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2865000069141388},{"id":"https://openalex.org/C26831200","wikidata":"https://www.wikidata.org/wiki/Q16963953","display_name":"Marginal structural model","level":3,"score":0.27950000762939453},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.2793000042438507},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.27869999408721924},{"id":"https://openalex.org/C2777984932","wikidata":"https://www.wikidata.org/wiki/Q7336293","display_name":"Risk of mortality","level":2,"score":0.27239999175071716},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.2718000113964081},{"id":"https://openalex.org/C3018095205","wikidata":"https://www.wikidata.org/wiki/Q55641553","display_name":"Real world evidence","level":2,"score":0.25189998745918274}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofag630","doi":"https://doi.org/10.1093/ofid/ofag630","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag630","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13732734","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13732734/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13732734/pdf/ofag630.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"},{"id":"pmid:42985210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42985210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open forum infectious diseases","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofag630","doi":"https://doi.org/10.1093/ofid/ofag630","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofag630","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308347","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320310420","display_name":"CSL Behring","ror":"https://ror.org/01jxhxv92"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320319071","display_name":"Moderna","ror":"https://ror.org/01xm4wg91"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225262109.pdf","grobid_xml":"https://content.openalex.org/works/W7225262109.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W2071066672","https://openalex.org/W2074360668","https://openalex.org/W2735301415","https://openalex.org/W2808135930","https://openalex.org/W3013468450","https://openalex.org/W3022164665","https://openalex.org/W3034985956","https://openalex.org/W3097738396","https://openalex.org/W3110492449","https://openalex.org/W3115815435","https://openalex.org/W3131672926","https://openalex.org/W3141051485","https://openalex.org/W3164452827","https://openalex.org/W3215208029","https://openalex.org/W4205682741","https://openalex.org/W4206038052","https://openalex.org/W4220932802","https://openalex.org/W4282916578","https://openalex.org/W4366237423","https://openalex.org/W4385715304","https://openalex.org/W4399302215"],"related_works":["https://openalex.org/W4385715304","https://openalex.org/W4412443468","https://openalex.org/W7128472661","https://openalex.org/W4302763581","https://openalex.org/W4387498926","https://openalex.org/W4403409057","https://openalex.org/W4405109324","https://openalex.org/W7128731395","https://openalex.org/W4293510936","https://openalex.org/W4408142373"],"abstract_inverted_index":{"Background:":[0],"Patients":[1,75],"who":[2,37,78,225],"were":[3,5,79,195,226],"immunocompromised":[4,39,227],"largely":[6],"excluded":[7],"from":[8,70],"COVID-19":[9,87,224],"clinical":[10],"trials,":[11],"and":[12,40,59,67,84,92,103,127,160,181,203,251],"real-world":[13],"evidence":[14],"on":[15],"remdesivir":[16,26,110,131,231],"effectiveness":[17],"has":[18],"produced":[19],"conflicting":[20],"results.":[21],"We":[22,45,96],"evaluated":[23],"whether":[24],"early":[25,155,177,187,211,234],"initiation":[27,113,120,129,180,212],"(vs":[28],"late":[29,179,238],"or":[30,239],"never)":[31],"reduces":[32],"in-hospital":[33,99,150,219],"mortality":[34,100,151,220],"among":[35],"patients":[36,138,222],"are":[38],"hospitalized":[41,85],"with":[42,57,65,223,237],"COVID-19.":[43],"Methods:":[44],"conducted":[46],"a":[47,52],"retrospective":[48],"cohort":[49],"study":[50],"using":[51],"target":[53],"trial":[54],"emulation":[55],"framework":[56],"clone-censor-weighting":[58],"deidentified":[60],"hospital":[61],"chargemaster":[62],"data":[63],"combined":[64],"medical":[66],"pharmacy":[68],"claims":[69],"approximately":[71],"400":[72],"US":[73],"hospitals.":[74],"included":[76],"those":[77],"immunocompromised,":[80],"aged":[81],"\u226512":[82],"years,":[83],"for":[86,108,154,158,162,176,186,221],"between":[88],"1":[89],"May":[90],"2020":[91],"3":[93,109,122],"December":[94],"2023.":[95],"assessed":[97],"all-cause":[98],"within":[101,114,121],"14":[102,165],"28":[104,192],"days":[105,116,125],"of":[106,117,130,149,210,213,218,246,249],"admission":[107,118],"treatment":[111],"regimens:":[112],"2":[115],"(\"early\"),":[119],"to":[123],"7":[124],"(\"late\"),":[126],"no":[128],"(\"never\").":[132],"Results:":[133],"Among":[134],"97":[135],"587":[136],"eligible":[137],"(median":[139],"age,":[140,200,247],"71":[141],"years;":[142],"51%":[143],"female),":[144],"the":[145,167],"14-day":[146],"cumulative":[147],"risk":[148,170,217],"was":[152,171,228,232,243],"9.2%":[153],"remdesivir,":[156],"10.1%":[157],"late,":[159],"11.8%":[161],"never.":[163,240],"At":[164,191],"days,":[166,193],"adjusted":[168],"relative":[169],"0.91":[172],"(95%":[173,183],"CI,":[174,184],".86-.97)":[175],"vs":[178,188],"0.78":[182],".75-.81)":[185],"never":[189],"initiation.":[190],"trends":[194],"similar.":[196],"Subgroup":[197],"analyses":[198],"by":[199],"variant":[201,252],"era,":[202],"immunosuppression":[204],"severity":[205,248],"yielded":[206],"similarly":[207],"protective":[208],"effects":[209],"remdesivir.":[214],"Conclusions:":[215],"The":[216],"lower":[229],"when":[230],"administered":[233],"as":[235],"compared":[236],"This":[241],"result":[242],"consistent":[244],"regardless":[245],"immunosuppression,":[250],"era.":[253]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-05T00:00:00"}